AI Revolution in Drug Development with Dave Hallett
Episode Overview
AI is significantly reducing the time and cost involved in drug development. Traditional drug development methods can take up to 15 years and cost billions. AI can predict which patients will respond to specific drugs, saving on clinical trial costs. The pharmaceutical industry is increasingly integrating AI to improve efficiency. Expert insights into the future of healthcare and pharmaceuticals.
The current estimates that the average cost of developing one new successful drug is something like three billion dollars and it's only going one way unfortunately
In this episode of The Relaxback UK Show, host Mike Dilke dives into the fascinating world of AI in drug development with guest Dave Hallett from Accenture. Dave, an expert in using artificial intelligence to speed up the drug discovery process, shares insights into how AI is revolutionising the pharmaceutical industry. You'll learn about the staggering costs and timeframes involved in developing new drugs and how AI is making significant strides in reducing these barriers.
From the traditional methods of drug development to the cutting-edge use of AI, this episode covers it all. Dave explains how AI can predict which patients will respond to certain drugs, potentially saving billions in clinical trial costs and bringing life-saving medications to market faster. Mike also brings a touch of humour as he navigates through complex topics, making them accessible and engaging.
Whether you're interested in the science behind drug development or just curious about how AI is changing the healthcare landscape, this episode has something for everyone. Tune in for a blend of expert knowledge, practical insights, and a few laughs along the way.